# A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Clinical trial · Janssen Research & Development, LLC

- Archive id: nct:NCT00679627
- Published: 2008-05-19
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT00679627
- Source URL: https://clinicaltrials.gov/study/NCT00679627
- Provenance: clinicaltrials

## Abstract

The purpose of this study is to compare the effectiveness and safety of 2 years of treatment with galantamine as compared with placebo of patients who have mild to moderately severe Alzheimer's disease (AD).

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- status: TERMINATED
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 2051
- sponsor: Janssen Research & Development, LLC
- conditions: Alzheimer's Disease
- interventions: DRUG: Galantamine; DRUG: Placebo
- start date: 2008-06-01
- primary completion date: 2012-04-01
- has results: true
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.